Join BSMA's Community!
Please share with peers and forward this notice to whomever it is relevant. Thank you.
Wednesday, Sept. 25, 2019 at 10:00am PST; 12:00pm CST; 1:00pm EST
Please JOIN our cold chain experts from GSK Vaccines, Portola Pharmaceuticals, Skycell & BSMA to learn how to improve the quality, financial & environmental performance of your biopharma cold chain.
Making the switch:
The Impact on Costs, Quality and Sustainability of Cold Chain Shipments 
“Since the implementation of the hybrid container solution, our CAPA reports have decreased by 100%.” Chris Bert, Quality Assurance Manager, GSK Vaccines
Whether vaccines or a newly launched product, these goods need particularly careful and accurate protection to ensure patient safety.
GSK Vaccines and Portola Pharmaceuticals share with us how they learned to say NO to temperature variations by switching to hybrid packaging and managed to execute implementation in just months.

Learn from the best!
Enhance the triple bottom line for your cold chain logistics:
  • People: Enable them to perform daily tasks simpler, safer and faster
  • Profit: The true value of eliminating temperature excursions
  • Planet: Reduce the CO2 footprint through environmental-friendly solutions
J oin this webinar to see how SkyCell can help you
upgrade the 3PS: People, Profit, Planet
Panelist: Chris Bert, Quality Assurance Manager, GSK Vaccines
Chris is a Quality Assurance Manager for GlaxoSmithKline at their North America Vaccine Regional Distribution Center. During his decade long tenure at GSK, he has held responsibilities related to reviewing and reacting to temperature data during the transport of temperature sensitive vaccines. Throughout his 17 years in Quality Assurance, he has been involved with cold chain transportation by road, air, sea, and in various passive and active packaging solutions. Chris earned a degree in Political Science from Messiah College, PA
Panelist: Patrick Pillsbury, Director, Logistics and Global Trade Compliance, Portola Pharmaceuticals
Patrick is a licensed U.S. Customs Broker with an advanced degree in Transportation and Logistics (M.S.), Patrick currently works for Portola Pharmaceuticals, Inc. in S. San Francisco as Associate Director, Global Trade Compliance and Logistics. At Portola, Patrick leads all aspects of distribution activities, including transportation validation and qualification of both active and passive cold-chain solutions, carrier management, lane risk assessments, and cloud-based visibility platforms centered on cold-chain data and transportation management. Prior to Portola, he managed the logistics and trade compliance functions for Pharmacyclics, Inc. in Sunnyvale, CA. This, following a successful tenure in freight forwarding and ocean freight transportation, which included stints with large carrier groups such as Hanjin Shipping, Hamburg Sud and Hapag-Lloyd, in both sales and pricing roles.
Panel Leader: Larry Tillem, Business Development Director, SkyCell North America, Inc.
Larry is responsible for SkyCell’s overall sales and major relationships throughout the America’s region. He joined SkyCell AG in 2018 to establish commercial and foundational development in North America after a +30 year career in the logistics and freight forwarding industry. In the decade prior to joining SkyCell, Larry was a dedicated global customer manager at DHL & Panalpina, with responsibility for their top-tier Life Sciences & Healthcare sector clients. He lives in the Boston area with his wife and daughter.
SkyCell ( ) is a Swiss-based, award-winning provider of temperature-controlled container solutions with a special focus on serving global pharma companies and sustainability. We are driven by our mission to supply the safest pharma containers worldwide. This is achieved through our unique combination of hardware, software and service, which enables us to master logistical challenges and eliminate temperature excursion. Hyper-focused on sustainability, SkyCell has GDP & ISO certification coupled with the fastest growing fleet, already containing the largest number of IoT pharma containers in the airfreight industry. SkyCell has been externally audited to confirm our status as the industry-leading provider of excursion free temperature-controlled pharmaceutical container solutions.
After registering, you will receive a confirmation email containing information about joining the webinar. Also, when you receive this confirmation, there is a link to add this event to your calendar, please click on it.